What should I do if I become drug-resistant after taking Temsirolimus?

Temsirolimus significantly improved progression-free survival and, in a small number of patients with renal cell carcinoma (RCC) overall survival. However, the benefits of temsirolimus treatment are transient and rapid disease progression occurs with long-term treatment. The mechanisms behind acquired resistance are not fully understood. Cell culture studies indicate that feedback activation of the PI3K-Akt signaling pathway is caused by inhibition of mTOR complex 1 (mTORC1).

Temsirolimus is an anti-tumor drug. If a patient develops resistance after taking temsirolimus, it means that the drug has failed to treat the tumor in the body. In this case, the patient should contact a doctor or oncologist immediately. Sometimes, combining different types of drugs or trying other anti-tumor drugs can improve the effectiveness of treatment. There are many different types of drugs available to treat cancer. Your doctor will choose the most appropriate drug for your patient based on your condition and individual differences. Everyone’s constitution is different and their resistance to drugs is also different. If drug resistance develops after using the drug, please inform your doctor in time and do not adjust the drug dosage yourself.

The original drug temsirolimus has not yet been marketed in China, and therefore cannot be included in domestic medical insurance. The original temsirolimus drug marketed overseas has a Turkish version and a European version. The ingredients of the two are basically the same. The price of each box of 30mg/1.2mL may be more than 10,000 yuan, and the price of 25mg/mL may be around 3,000 yuan per box (the price may fluctuate due to exchange rates). There is currently no generic version of temsirolimus available on the market. For more drug information and specific prices, please consult a medical consultant.